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Letter to the Editor
To the Editor—As part of the ISPOR Education
Steering Committee, the ISPOR Fellowship Task
Force was formed in the spring of 2000. The Task
Force’s mission is to deﬁne the fundamentals of a
core curriculum for pharmacoeconomic and out-
comes research (PE/OR) fellowships, as well as to
foster knowledge of these programs among students
of various scientiﬁc and professional backgrounds.
As a result, in 2001 the Task Force began a research
study to provide insight into the characteristics and
components of the PE/OR fellowship programs.
The results of this study have recently been
described in two articles published in the American
Journal of Pharmaceutical Education [1,2]. A brief
description of the main research ﬁndings is
presented.
PE/OR fellowship programs have been in exist-
ence in the United States for more than a decade.
With the increasing number of programs, however,
it has become difﬁcult to quantify the exact
number of programs offered, and little is known
about how these programs are structured [3]. The
objectives of the study conducted by the ISPOR
Fellowship Task Force were: 1) to describe the
organizational structures and educational compo-
nents of PE/OR fellowship programs within the
United States and 2) to determine the extent to
which these programs adhere to the 1999 Ameri-
can College of Clinical Pharmacy (ACCP) PE fel-
lowships guidelines.
From November 2001 through December 2001,
the Task Force conducted a cross-sectional, Web-
based survey via the ISPOR Web site. The survey
population consisted of fellows as well as precep-
tors involved in a PE/OR fellowship, who were
identiﬁed by collecting information through differ-
ent sources including the ACCP and ISPOR direc-
tories for these programs. The Task Force developed
a set of three questionnaires, which were adminis-
tered, respectively, to current fellows enrolled in a
fellowship, to fellows who had ﬁnished a fellow-
ship, and to preceptors currently involved in a fel-
lowship. Of the 151 individuals completing the
survey, 33 current fellows, 38 former fellows, and
38 preceptors met the inclusion criteria.
According to fellows and preceptors’ responses,
the results of the study revealed that PE/OR fellow-
ships have numerous similarities in terms of their
general characteristics, as well as their organiza-
tional and educational aspects [1,2]. Therefore,
a common proﬁle for these programs can be
described as shown in Table 1. With a program
2 years in length, sponsored by the pharmaceutical
industry, and conducted predominantly in academic
and pharmaceutical industry sites, PE/OR fellow-
ships reportedly provide trainees with adequate
resources to carry out scientiﬁc research [2]. In
addition, programs offer applicants exposure to a
variety of types of research design and analysis to
enhance their knowledge about PE/OR.
According to preceptors’ opinions, current PE/
OR fellowships appear to adhere to the 1999
ACCP guidelines [1]. In particular, preceptors
reported that programs show signiﬁcant compli-
ance with the main aspects of the guidelines,
which deﬁne both the structure and the process
of fellowships. Few preceptors, however, indi-
cated that their programs currently offer trainees
hands-on research activities at the level suggested
by these guidelines.
In conclusion, as an initiative of the IPSOR
Fellowship Task Force, this is the ﬁrst study to
describe the current state of PE/OR fellowship
programs in the United States. The results of
these investigations provide substantial insight to
institutions and organizations wishing to develop
new or reﬁne existing PE/OR fellowship pro-
grams.—Vittorio Maio, PharmD, MS, Ofﬁce of
Health Policy, Clinical Outcomes, Thomas Jeffer-
son University.
Table 1 Common proﬁle of  a US-based pharmacoeco-
nomic/outcomes research fellowship program based on fel-
lows and preceptors’ responses*
Organizational features
1. Two-year program.
2. Sponsored by pharmaceutical industry.
3. Conducted primarily in academic and pharmaceutical industry 
sites.
4. Available facilities, including medical library, computer center, 
medical database
5. Average fellow’s salary: US$30,000– US$40,000 (year 2001).
Educational features
6. Skills taught, including economic analysis and methodologies, as 
well as research design and methods.
7. Software applications, including SAS and Access.
8. Exposure to PE/OR design and analysis.
9. Research skills, including the conceptualization, 
operationalization, data management, and application of  
research projects.
*Adapted from Maio et al. [1,2].
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